KZA 0.00% 8.0¢ kazia therapeutics limited

SNO August Brain Mets Conf, page-3

  1. 6,852 Posts.
    lightbulb Created with Sketch. 2536
    Secondary Outcome Measures :
    1. CBR [ Time Frame: 18 and 24 weeks ]
      rate of patients with clinical benefit at 18 and 24 weeks
    2. https://clinicaltrials.gov/ct2/show/NCT03765983
    Maybe considering the trial started dec 2018 and first enrolment Feb 2019. Aug would spot on for 18 week or even 24 week metrics.
    Watch this spot for sure as it was highlighted in the Kazia June newsletters of coming dates
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.